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Bartonella henselae, a fastidious Gram-negative
bacterium, has been known as the principal
causative agent of cat scratch disease (CSD) only
since 1992.1 Thereafter, a broad spectrum of 
clinical manifestations, including Parinaud ocu-
loglandular syndrome, bacillary angiomatosis,
peliosis hepatica, bacteremia, endocarditis, and
aseptic meningitis, were recognized as B. henselae
infections.2 yImmunocompetent hosts usuall
present with typical CSD, which is characterized
by a primary granulomatous skin lesion that de-
velops 3–10 days after contact with an infected
cat. Development of this lesion is followed by en-
largement of the regional lymph nodes,3 and pro-
longed fever in children.4 Lymphadenopathy is
the most common clinical manifestation of CSD
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Background/Purpose: Bartonella henselae is the causative agent of cat scratch disease (CSD), manifesting as
fever and acute regional lymphadenopathy. Although serologic testing is the reference method for diagno-
sis, successful use of immunohistochemical (IHC) stain of regional lymph nodes for the diagnosis of CSD
yhas been reported. To determine the characterization and diagnostic potential of IHC in lymphadenopath
of CSD, lymph nodes were excised from patients with suspected CSD for further evaluation.
Methods: Polyclonal antibody-based IHC studies were performed for the detection of B. henselae. Between
 January 2001 and December 2004, the reference laboratory of the Center for Disease Control, Taiwan,
received a total of 377 sera from 352 reported suspected CSD cases. Twenty-three formalin-fixed paraffin-
gembedded lymph nodes from 16 patients and two skin biopsies from two patients suspected of havin
CSD were included in this study. Nine of them were serologically confirmed to have CSD and the others
were seronegative but suspected to have CSD by the attending physicians. Seven lymph node specimens
were obtained from tuberculosis patients for comparison.
Results: We demonstrated that the microorganisms existed in the cytoplasm of histiocytes within the
granulomatous lesions in nine lymph nodes and one skin biopsy. Among the nine lymph nodes with
IHC(+) stains, three were seronegative. On the other hand, three cases were IHC(+) and six cases were
IHC(−) among nine seronegative patients. In addition, two seronegative patients with skin biopsy showed
one IHC(+) and one IHC(−).
Conclusion: IHC can contribute to the etiologic diagnosis of B. henselae ylymphadenopathy when serolog
and molecular techniques are not available. [J Formos Med Assoc 2006;105(11):911–917]
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ORIGINAL ARTICLE
and is described in more than 80% of all cases.5
The diagnosis of CSD is reached using pathogen
isolation, polymerase chain reaction (PCR) am-
plification of B. henselae, and serologic testing,
such as indirect immunofluorescent antibody
(IFA) assay and enzyme-linked immunosorbent
assay (ELISA). Among these, the development of
molecular biology tools, especially the use of
PCR, improved the identification of these fastidi-
ous bacteria. In humans, serologic testing (mainly
IFA) is the reference test for the diagnosis of CSD.
An IgG anti-B. henselae antibody titer ≥ 1:64 is
considered to be positive for infection when pa-
tients are tested at least 2–3 weeks after inocula-
tion. Successful use of immunohistochemical
(IHC) stain in cases of bacillary angiomatosis,6
Bartonella endocarditis,7 Bartonella uveitis8 and
splenic rupture caused by B. henselae9 has been
reported. To determine the IHC characteristics of
lymphadenopathy and increase the diagnostic
potential of IHC in lymph node and skin of 
CSD patients, we used excised lymph nodes of
patients suspected to have CSD for IHC study.
Methods
Samples
Between January 2001 and December 2004, the 
reference laboratory of the Center for Disease
Control, Taiwan, received a total of 377 sera from
352 reported suspected CSD cases. All sera were
tested by IFA assay. Twenty-three formalin-fixed
paraffin-embedded lymph nodes from 16 patients
and two skin biopsies from two patients suspected
of having CSD, and seven lymph nodes from pa-
tients confirmed to have tuberculosis were in-
cluded in this study. Half of the 18 cases were
serologically confirmed CSD cases and the others
were suspected by the attending doctors to be CSD.
Histopathologic investigation
The lymph node and skin specimens were fixed in
10% buffered formalin, embedded in paraffin, cut
at 2–3μm, and routinely stained with hematoxylin
fand eosin. The negative controls consisted o
seven paraffin-embedded lymph nodes from pa-
tients with positive acid-fast stain or Mycobacterium
tuberculosis culture. Warthin-Starry staining was also
performed in our study.
DNA extraction
DNA was extracted from the formalin-fixed,
paraffin-embedded lymph node and skin biop-
Asies by using a Blood & Tissue Genomic DN
Extraction Miniprep System (Viogene®, Taipei,
Taiwan) according to the manufacturer’s instruc-
tions. The extracted DNA was used as a template
in the PCR assays with the amplified β-actin gene
as internal control.10 Purified DNA from a cul-
tured strain of B. henselae (Houston-1; ATCC
49882) was used as a positive control.
Amplification of Bartonella DNA
Two-step semi-nested PCR with three primers
PAPn1 (5′-TTCTAGGAGTTGAAACCGAT-3′), PAP-
n2 (5′-GAAACACCACCAGCAACATA-3′) and PAP-
ns2 (5′-GCACCAGACCATTTTTCCTT-3′) was used
to amplify a 275 bp and 209 bp fragment of the
Bartonella pap31 gene.11 In the first step (PCR1),
10 μL of extracted DNA was amplified using pri-
mers PAPn1 and PAPn2; in the second step
(PCR2), 10μL of 1:500 diluted PCR1 amplifica-
tion product was further amplified using primers
PAPn1 and PAPns2. The 25μL reaction mixture
consisted of primer (40 ng/μL each), bovine serum
albumin (0.5μg/μL), MgCl2 (2 mM), dNTP mix-
ture (0.2 mM), 10X buffer, Taq DNA polymerase
enzyme (1.25 U), sterile water, and 10μ AL of a DN
rsample. PCR amplification was performed unde
fthe following conditions: an initial 3 minutes o
denaturing at 94° fC was followed by 44 cycles o
denaturing for 30 seconds at 94° rC, annealing fo
30 seconds at 56°C, and extension for 45 seconds
at 72°C. The amplification was completed by hold-
ing the reaction mixture at 72°C for 10 minutes to
allow complete extension of the PCR products.
PCR products were separated by electrophoresis
on 2% agarose gels and visualized by staining with
ethidium bromide.
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B. henselae indirect immunofluorescence
antibody test
The antibody titers to B. henselae were determined
by indirect IFA assay, using B. henselae (ATCC
49882) as an antigen.1,12 The strain was inoculated
to Vero cell (CCRC 60013, Bioresources Collection
and Research Center, Taiwan) and incubated at
37°C with 5% CO2. After incubation, the infected
cells were distributed into each well of 12-hole
Teflon printed slides (Electron Microscopy Scien-
ces, Fort Washington, PA, USA), and the slides were
incubated at 37°C with 5% CO2 overnight. After in-
cubation, the slides were fixed in acetone and air-
dried. The slides were stored at –70°C. For the IFA
assay, frozen sera were thawed at room temperature
and treated at 56°C for 30 minutes for heat inacti-
vation. The serum was serially diluted from 1:32 to
1:512 by twofold dilutions using phosphate
buffered saline (PBS) with 10% skim milk. Thirty
microliters of diluted serum was dropped into each
well of the previously prepared slides. Slides were
incubated at 37°C for 40 minutes and washed with
PBS for 10 minutes. Fluorescein-labeled goat anti-
human IgG (Kirkegaard & Perry Laboratories Inc.,
Gaithersburg, MD, USA) was diluted at 1:400 in
PBS, and the mixture was applied to each well. The
slides were incubated at 37°C for 40 minutes,
washed with PBS for 10 minutes, and washed again
with double distilled water for 10 minutes prior to
examining with a fluorescent microscope (magnifi-
cation, ˜400). The intensity of the bacillus-specific
fluorescence was scored subjectively from 1 to 4,
and a fluorescence score ≥2 at a dilution of 1:64
was considered to be positive.
Polyclonal antibody preparation
For the preparation of polyclonal antibodies, bac-
terial strains, B. henselae Houston-1 (ATCC 49882)
and B. henselae Marseille (strain U4, from Prof.
Chomel, UC Davis), were cultivated on chocolate-
agar plates at 37°C in 5% CO2. Bacteria were sus-
pended in adjuvant and injected into New Zealand
white rabbits. Serum antibody levels were deter-
mined 3 weeks later by IFA assay. The antibody
titers were 1:4000 for the Houston-1 strain and
1:3000 for the U4 strain. There was no cross
reaction to other bacteria, such as Streptobacillus
moniliformis.
Immunohistologic analysis
Immunohistochemical testing was performed on
5-μm-thick, formalin-fixed, paraffin-embedded
tissue sections. After deparaffinization, rehydra-
tion, proteinase K digestion and blocking, each
ttissue section was incubated for 60 minutes a
room temperature with polyclonal rabbit anti-B.
henselae Houston-1 and anti-B. henselae Marseille
antibodies prepared as described in the preced-
ing section and diluted 1:100 in tris-buffered saline.
After incubation with the primary antibody, im-
munodetection was performed with biotinylated
goat anti-rabbit and anti-mouse immunoglob-
ulins (DAKO, Kyoto, Japan), followed by alka-
line phosphatase conjugated streptavidin (DAKO).
The slides were rinsed, incubated in naphthol
phosphate–fast red substrate (Sigma-Aldrich Corp.,
St. Louis, MO, USA), counterstained with Mayer’s
fhematoxylin stain, and mounted with the use o
aqueous mounting medium.
Results
Demography of suspected CSD cases
Out of the 352 patients with suspected CSD, 99
were seropositive; of these 99, 51 were male and
48 were female, 37 were children and 62 were
adults. There were no statistical differences in gen-
der and age by χ2 test. The number of reported
CSD cases showed an increasing trend from 2001
to 2004 (37 cases in 2001, 69 in 2002, 126 in
2003, 120 in 2004); 50.9% (179/352) of the
cases occurred in summer (Figure 1). The clinical
manifestations of the 18 cases for IHC study are
shown in the Table. Ten patients had animal con-
tact and half of them (9/18) had fever. Sixteen
tout of 18 suspected CSD patients had at leas
 one enlarged lymph node, located at 19 sites
including the neck (2/19), elbow (3/19), axilla
(8/19), groin (4/19) and thigh (2/19).
fImmunohistochemistry o  lymph nodes in CSD
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Histopathology and immunohistochemistry
Histopathologic examination of the 23 lymph
nodes showed lesions of necrotizing granuloma-
tous inflammation, microabscess, lymphoid hy-
perplasia and giant cells (data not shown). IHC
staining was used to demonstrate B. henselae in
human lymph node and skin tissues. Of the 23
lymph node specimens available for immuno-
histologic study, B. henselae was identified in nine
specimens (Table). The lymph nodes of seven tu-
berculosis confirmed cases were all negative by
IHC. The positive results showed that the bacte-
ria were identified in the cytoplasm of histiocytes
within granulomatous lesions (Figures 2A and
2B), and superimposed on that in the Warthin-
Starry stain (Figure 2C). The positive control,
antigen slides for IFA, showed the same results
with intracytoplasmic distribution of the bacter-
ial colonies in the Vero cells (Figure 2D).
Detection of Bartonella DNA
DNA extraction was performed from only 15
rspecimens, and 14 of them were positive fo
Bartonella pap31 gene by PCR (Table). An ethi-
dium bromide-stained 2% agarose gel demon-
strating the amplified products of the template
Table. Clinical manifestations, serologic, IHC and PCR results of 18 suspected cat scratch disease cases
Case IFA IHC PCR Cat contact/scratch Fever LAP
1 1:512 + + + + Axillary, elbow
2 1:512 – + Axillary, elbow
3 1:256 + + + + Thigh
4 1:256 + + + Axillary
5 1:128 – ND + + Inguinal
6 1:128 + + + Axillary
7 1:128 + ND + + Inguinal
8 1:128 + + + Axillary, elbow
9 1:64 + + Axillary
10 – – + + Inguinal
11 – – + Axillary
12 – – + Dog bite + Axillary
13 – – – + Cervical
14 – – ND + Cervical
15 – – + + *
16 – + + + Thigh
17 – + + *
18 – + + + Inguinal
*Skin biopsies. IFA = indirect immunofluorescent antibody assay; IHC = immunohistochemistry stain; PCR = polymerase chain reaction;
LAP = lymphadenopathy; ND = not done; + = positive; – = negative.
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of cat scratch disease in Taiwan
(a total of 352 reported cases,
2001–2004). Most of the
reported cases occurred 
between June and September.
DNA derived from lymph node specimens is
shown in Figure 3.
Discussion
Physicians in Taiwan are increasingly able to
recognize the symptoms of CSD, and there are
escalating reports of CSD cases year after year.
Lymphadenopathy and fever of unknown origin
are the two main symptoms, which contribute
to the diagnosis of CSD. The location of lym-
phadenopathy in CSD patients depends on the
 scratch or bite sites. In a study of 246 CSD
patients, the most commonly infected sites were
the neck (43% of patients), followed by the
axilla (38%) and groin (20%). Thirty-seven per-
tcent of patients have enlarged lymph nodes a
more than one site.14 In our study, the axilla
was the most commonly infected site (Table).
rAbout 51% of the cases occurred in the summe
from June to September, suggesting that warm
fand humid environments favor the growth o
potential arthropod vectors, such as fleas. Previous
studies from America13 and Japan15 have reported
high seroprevalence to B. henselae infection in
domestic cats.
yThe pathologic findings of lymph node biops
specimens from immunocompetent patients with
CSD varied with the stages of infection. Early in
the course of the disease, specimens showed lym-
phoid hyperplasia, arteriolar proliferation, and
fImmunohistochemistry o  lymph nodes in CSD
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BA iF gure 2. h l dHistopat o ogic an
immunohistochemical (IHC) localization of
Bartonella henselae in specimens and the
antigen slide for indirect immunofluorescent
antibody assay. (A) Bacterial colonies in gran-
uloma (IHC, 100˜). (B) Intracytoplasmic dis-
tribution of bacteria (IHC, 400˜). (C) Darkly
stained bacilli consistent with Bartonella
(arrow) (Warthin-Starry silver, 400˜). (D)
Bacteria located in the cytoplasm of Vero
cells (positive control) (IHC, 400˜).
iF gure 3. fPolymerase chain reaction o  the pap31 gene of
Bartonella henselae from lymph node specimens. Lane M,
standard 100 bp molecular ladder; lanes 1–7, lymph node
DNA of patients with suspected cat scratch disease; lane
8, lymph node DNA of tuberculosis confirmed patient;
lane 9, B. henselae DNA; lane 10, sterile water.
M 1 2 3 4 5 6 7 8 9 10
275 bp
209 bp
reticulum cell hyperplasia. Subsequently, granu-
lomas appeared, often with central necrosis; at
this stage, multinucleated giant cells may become
evident. Late in the disease, the specimen charac-
teristically shows multiple stellate microab-
scesses.16 In the Warthin-starry stain, rod-shaped
bacteria were clustered in cytoplasmic locations
such as the vessel walls of lymph node tissue,17,18
or in dermal macrophages.18 The pathogen could
also be found at extracellular locations such as in
the necrotic debris of lymph nodes17,18 or the
skin.18 The silver stain results demonstrated the
intracellular location of the bacteria. On IHC
study, the extracellular locations of B. henselae
were in the cardiac valve,7 spleen9 and vitreous
fluid.8 Intracellular B. henselae was also reported
in the dermal cells of bacillary angiomatosis in
CSD patients with AIDS6 and also demonstrated
in histiocytes of lymphoid tissue and Vero cells
of IFA coated slide in our study. In contrast to the
IHC results, B. henselae were granular in lymph
node tissue and rod-shaped on IFA coated slides.
The difference may be attributed to the damag-
ing effects of formalin tissue fixation on the anti-
gen of the pathogen. Attempts to amplify the
htrA gene19 and gltA gene20 of B. henselae with
single-step PCR from lymph node tissue were
unsuccessful, and the DNA products were 414 bp
and 380 bp, respectively. The success of a PCR-
based study of fixed, paraffin-embedded mate-
rial depends on several factors, including the
fixative used in tissue processing, the duration of
the fixation, the age of the paraffin block, and
the length of the DNA fragment to be amplified.
Only 60% of 5-year-old specimens were suffi-
cient for amplification of a 536 bp fragment,21
and the various steps of fixation and embedding
of the tissue are known to damage DNA.22
We chose nested PCR to increase the sensitiv-
ity of the test, and the results indeed showed
high sensitivity. However, skillful technique and
a well-controlled laboratory environment are
required to avoid false-positive results. When
serology and molecular techniques are not avail-
able, IHC can contribute to the etiologic diagno-
sis of Bartonella lymphadenopathy.
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